Figure 1From: Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT studyPatient outcome with the two different tests for CTC detestion. Progression-free survival for (a) CellSearch™ and (b) AdnaTest BreastCancer™. Overall survival for (c) CellSearch™ and (d) AdnaTest BreastCancer™. CTC, circulating tumor cell; n.s., not significant.Back to article page